Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial
Authors
Yuankai Shi,
Hang SuYongping Song,
Wenqi Jiang,
Xiuhua Sun,
Wenbin Qian,
Wei Zhang,
Yuhuan Gao,
Zhengming Jin,
Jianfeng Zhou,
Chuan Jin,
Liqun Zou,
Lugui Qiu,
Wei Li,
Jianmin Yang,
Ming Hou,
Shan Zeng,
Qingyuan Zhang,
Jianda Hu,
Hui Zhou,
Yan Xiong +19 authors
,
Peng Liu Tip Tip